Early-Stage Funding: Fewer Start-Ups Raising Cash In '05
This article was originally published in Start Up
Executive Summary
Fundraising among biotech firms classified as start-ups by Windhover's Strategic Intelligence Systems was way down in the first quarter of 2005 compared to the same quarter in 2004, perhaps reflecting the growing difficulties of early-stage fundraising as venture capitalists focus on companies with clinical-stage projects.